跳转到主要内容
主页 / 资源 / 网络研讨会点播 / 新冠肺炎期间管理临床试验和监管提交策略的注意事项

新冠肺炎期间管理临床试验和监管提交策略的注意事项

20200428
网络研讨会点播
YouTube video

COVID-19 has the potential to negatively impact critical activities such as patient recruitment, patient safety and ensuring data integrity. Thus, clinical developers should review their planned regulatory filing strategies to determine if modifications are required. Attend this webinar to learn mitigation strategies and best practices that you can begin implementing now.

演讲嘉宾:
Demetrius Carter, SVP Services Operations & Regulatory Services
Elaine B. Taylor, VP, Regulatory Strategy and Policy

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software